HUTCHMED (China) (HCM) Payables (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Payables for 10 consecutive years, with $70.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Payables rose 7.0% to $70.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.5 million, a 7.0% increase, with the full-year FY2025 number at $70.5 million, up 7.0% from a year prior.
  • Payables was $70.5 million for Q4 2025 at HUTCHMED (China), up from $65.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $70.5 million in Q4 2025 to a low of $3.6 million in Q4 2022.
  • A 5-year average of $42.8 million and a median of $41.2 million in 2021 define the central range for Payables.
  • Peak YoY movement for Payables: plummeted 91.22% in 2022, then skyrocketed 804.84% in 2023.
  • HUTCHMED (China)'s Payables stood at $41.2 million in 2021, then tumbled by 91.22% to $3.6 million in 2022, then surged by 804.84% to $32.7 million in 2023, then soared by 101.39% to $65.9 million in 2024, then rose by 7.0% to $70.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Payables are $70.5 million (Q4 2025), $65.9 million (Q4 2024), and $32.7 million (Q4 2023).